
The barometer shows that in January, 85% of companies said they considered their level of activity to be "normal".Most of the companies questioned felt that the pandemic would remain confined to China.
The rise in pessimism was all the more rapid thereafter. As early as March, only 15% of the companies in the barometer were still describing their business as normal. Between April and June, this percentage had fallen to between 5 % and 6 %. In April and May, 73 % of companies in the exhibition industry reported no activity.
The majority of companies surveyed expected a recovery in "local" and "national" trade fairs in the second half of 2020. However, this recovery is likely to be slow, with two out of three companies expecting to see a return to reduced activity only in the fourth quarter. At the same time, a majority (54%) felt that the return of international trade fairs would not take place before the first half of 2021The majority of companies (60%) thought that their business would recover, either fully or to a lesser extent, in September, with confidence peaking in November at 68%.
However, there were variations from one continent to another. Unsurprisingly, the Asia-Pacific region was the first to experience a drop in activity. As early as January, only 73% of companies reported operating under "normal" conditions, a figure that had already fallen to 45% by February. The most pessimistic are companies based in the Middle East, Africa and Central and South America. In these two regions, a majority of companies expected that national exhibitions and trade fairs would not open until 2021.
The barometer also highlights the fact that 87% of MICE industry players worldwide have reduced their operating costs, 17% of them even managed to reduce their overall costs by more than 50%. We note that 44% of companies in the sector have succeeded in obtaining financial support at global level.
44% of companies in the sector suspended their investments, while the industry as a whole estimated that the measures taken to comply with the Covid-19 protocols had accounted for more than 10 % of their overall costs.


















